During this Insights interview with Genevieve Kumapley, PharmD, BCOP, on the Use of Oral Oncolytics in Palliative Care, part of the Oncology Stakeholders Summit, Spring 2015 series, Dr Kumapley discusses current guidelines for the delivery of palliative care and describes gaps in care.
Recent guidelines by the National Comprehensive Cancer Network and the American Society of Clinical Oncology recommend a multidisciplinary management approach when caring for patients, says Dr Kumapley, an oncology clinical pharmacy specialist for Saint Peter’s Healthcare System. Employing a multidisciplinary management approach is essential to providing the best quality of care, she adds, as such an approach enables providers to consider spiritual, psychosocial, and cultural issues that may be important to patients.
However, Dr Kumapley suggests that certain gaps in care need to be addressed; for instance, most palliative care is provided in the hospital, even though doing so earlier in a patient’s diagnosis and in the outpatient setting is equally important. Outpatient facilities are often where patients first receive their cancer diagnosis, says Dr Kumapley. Providing palliative care in the outpatient setting also increases reimbursement opportunities for cancer care teams, she suggests.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More